Login

AUXILIUM PHARMACEUTICALS INC 3 SEC Filings

Filed On Filing
20 Aug 2014 Form 3: Saik Andrew, CFO

No securities owned

07 Jul 2014 Form 3: Auxilium Pharmaceuticals Inc, 10% owner · NOVELION THERAPEUTICS INC.

Holds 0 shares of Common Shares, no par value

10 Jun 2014 Form 3: Flynn James E, 10% owner and 4 others

Holds 2,797,408 shares of Common Stock

25 Apr 2012 Form 3: Jobes Elizabeth Varki, Chief Compliance Officer

No securities owned

07 Feb 2012 Form 3: Glickman Mark A, SVP - Sales

No securities owned

07 Feb 2012 Form 3: Koven Andrew I, EVP, CAO, GC and Secretary

No securities owned

09 Dec 2011 Form 3: Adams Adrian, Director

No securities owned

03 Nov 2011 Form 3: Kessig Edward F, Senior Vice President, Sales

Holds 4,788 shares of Common Stock

03 Nov 2011 Form 3: Dudek Richard Michael Jr, Senior Vice Pres., Marketing
03 Nov 2011 Form 3: Armstrong Jennifer Lou, Senior Vice President, HR

Holds 1,300 shares of Common Stock

10 Aug 2011 Form 3: Tursi James Patrick, Chief Medical Officer

Holds 1,263 shares of Common Stock

20 Jun 2011 Form 3: Lurker Nancy, Director

No securities owned

20 Dec 2010 Form 3: Brandt Peter C., Director

No securities owned

26 Oct 2010 Form 3: Wills Alan, EVP, Corporate Development

No securities owned

28 Jul 2010 Form 3: Arcuri Edward J, EVP, Technical Operations

No securities owned

07 Jun 2010 Form 3: Friedman Paul A, Director

No securities owned

11 Mar 2010 Form 3: Baker Bros. Capital (GP), Llc, 10% owner and 2 others

Holds 6,683 shares of Common Stock

11 Mar 2010 Form 3: Baker Biotech Capital (GP), Llc, 10% owner and 2 others

Holds 953,409 shares of Common Stock

11 Mar 2010 Form 3: 14159 capital (GP), Llc, 10% owner and 2 others

Holds 132,335 shares of Common Stock

11 Mar 2010 Form 3: Baker Brothers Life Sciences Capital (GP), Llc, 10% owner and 2 others

Holds 4,544,034 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support